Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
eWeLL Co.,Ltd ( (JP:5038) ) has provided an update.
eWeLL Co., Ltd. reported strong non-consolidated results for the fiscal year ended December 31, 2025, with net sales rising 31.9% year on year to ¥3,392 million and net income climbing 34.6% to ¥1,088 million, reflecting high profitability metrics such as a 45.3% operating margin and robust returns on equity and assets. The company’s financial position also strengthened, with total assets increasing to ¥4,283 million, equity capital ratio holding at a solid 78.8%, and cash and cash equivalents expanding to ¥2,857 million, indicating ample liquidity to support growth and shareholder returns.
eWeLL continued to enhance shareholder value by raising its annual dividend from ¥12.00 to ¥16.00 per share for 2025 while maintaining a payout ratio of 22.3%, and it plans a further increase to ¥21.00 for 2026, signaling confidence in earnings sustainability. The company’s forecast for the fiscal year ending December 31, 2026, calls for another year of strong expansion, with net sales projected to grow 26.1% to ¥4,277 million and net income expected to rise 22.2% to ¥1,329 million, underscoring management’s expectations of continued operational momentum and reinforcing its competitive standing in the healthcare IT market.
Cash flow from operating activities improved markedly to ¥1,270 million in 2025, more than covering investing and financing outflows and contributing to the higher year-end cash balance. This combination of vigorous earnings growth, disciplined balance sheet management, and a steadily rising dividend profile suggests a favorable outlook for investors and supports eWeLL’s efforts to consolidate its position as a profitable, growth-oriented player in Japan’s healthcare technology sector.
The most recent analyst rating on (JP:5038) stock is a Buy with a Yen2929.00 price target. To see the full list of analyst forecasts on eWeLL Co.,Ltd stock, see the JP:5038 Stock Forecast page.
More about eWeLL Co.,Ltd
eWeLL Co., Ltd. is a Japan-based company listed on the Tokyo Stock Exchange that operates in the healthcare IT and related services space, focusing on digital solutions for medical and nursing care providers. The company generates recurring revenue through software and service offerings that support efficiency and compliance in the medical and care industries, positioning it within Japan’s growing healthcare technology market.
Average Trading Volume: 63,084
Technical Sentiment Signal: Hold
Current Market Cap: Yen37.98B
For an in-depth examination of 5038 stock, go to TipRanks’ Overview page.